Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5-Methyltetrahydrofolate (5-MTHF) is the primary biologically active, methylated form of folate (vitamin B9) found in blood and tissues. It is produced in the body by reduction and methylation of dietary folate or synthetic folic acid, via the enzyme methylenetetrahydrofolate reductase (MTHFR). 5-MTHF serves as the crucial methyl group donor in the remethylation of homocysteine to methionine, a step essential for cellular methylation reactions, DNA synthesis and repair, neurotransmitter production, and fetal development. Deficiency or impaired metabolism of 5-MTHF—particularly due to common polymorphisms in the MTHFR gene—can result in elevated homocysteine, with potential links to cardiovascular, neurodevelopmental, and neuropsychiatric disorders. Supplementation with L-methylfolate is sometimes used therapeutically, particularly in populations with known MTHFR mutations or absorption deficits.
Provides methyl groups for conversion of homocysteine to methionine, supporting methylation cycles and DNA synthesis
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5-Methyltetrahydrofolate (5-MTHF).